Video

Q&A With Jake Mann From the University of Cambridge: Looking at Comorbidities of Non-alcoholic Fatty Liver Disease

Author(s):

Hepatologists are seeing a growing number of patients with non-alcoholic fatty liver disease in their practices. Finding the most effective ways to treat them has become a focus of the field. A recent study also looked at the link between this and similar conditions and cardiovascular disease.

Hepatologists are seeing a growing number of patients with non-alcoholic fatty liver disease in their practices. Finding the most effective ways to treat them has become a focus of the field. A recent study also looked at the link between this and similar conditions and cardiovascular disease.

Jake Mann, from the University of Cambridge discussed the results of one such study during the 2015 International Liver Congress in Vienna.

Related Videos
FDA News Month in Review: September 2024
HCPLive Five at Maui Derm NP+PA Fall 2024 | Image Credit: HCPLive
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
Steve Nissen, MD | Credit: Cleveland Clinic
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
Sherona Bau, NP | Credit: UCLA Health
© 2024 MJH Life Sciences

All rights reserved.